References
- Abrams P, Freeman R, Anderstrom C, Mattiasson A. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998; 81: 801–10
- Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis. Urology 1997; 50: 90–6
- Chu DF, Tian JW, Liu WH, Li Z, Li YX. Poly(lactic-co-glycolic acid)microspheres for the controlled release of huperzine A: In vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chem Pharm Bull 2007; 55: 625–8
- Du L, Cheng JP, Chi Q, Qie JK, Liu Y, Mei XG. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Chem Pharm Bull 2006; 54: 1259–65
- FDA. 1997. Guidance for industry: Dissolution testing of immediate release solid oral dosage forms. Silver Spring, MD: Center for Drug Evaluation and Research, USA, p. 9.
- Freitas S, Merkle HP, Gander BJ. Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology. J Control Release 2005; 102: 313–32
- Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Colloids Surf B 2008; 61: 199–207
- Izumikawa S, Yoshioka S, Aso Y, Takeda Y. Preparation of poly (l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. J Controlled Release 1991; 15: 133–40
- Jacobsen LO, Kreilgard B, Hoeck U, Kristensen H. 2003. Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder, US Patent 6,517,864.
- Jiang CJ, Teng LS, Teng LR, Li CM, Li YX. Biodegradable PLGA microsphere for the controlled release of tolterodine derivative. J Biotechnol 2008; 136: S416–7
- Kerrebroeck PV, Kreder K, Jonas U, Zinner N, Wein AN. Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder. Urology 2001; 57: 414–21
- Knox ED, Stimmel GL. Clinical review of a long-acting, injectable formulation of risperidone. Clin Ther 2004; 26: 1994–2002
- Liu WH, Song JL, Liu K, Chu DF, Li YX. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease. J Control Release 2005; 107: 417–27
- Mao SR, Xu J, Cai CF. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007; 334: 137–48
- Nahata T, Saini TR. Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine. J Microencapsul 2008; 25: 426–33
- Nilvebrant L, Hallen B, Larsson G. Tolterodine, a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data. Life Sci 1997; 60: 1129–36
- Okada H, Toguchi H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug 1995; 12: 1–99
- Pahlman Z, Gozzi P. Serum protein binding of tolterodine and its major metabolites in humans and several animal species. Biopharm Drug Dispos 1999; 20: 91–9
- Patel P, Mundargi RC, Babu VR, Jain D, Rangaswamy V, Aminabhavi TM. Microencapsulation of doxycycline into poly(lactide-co-glycolide) by spray drying technique: Effect of polymer molecular weight on process parameters. J Appl Polym Sci 2008; 108: 4038–46
- Postlind H, Danielson A, Lindgren A, Andersson SH. A new muscarinic receptor antagonist is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Drug Metab Dispos 1998; 26: 289–93
- Schwach G, Oudry N, Delhomme S, Luck M, Lindner H, Gurny R. Biodegradable microparticles for sustained release of a new GnRH antagonist – Part I: Screening commercial PLGA and formulation technologies. Eur J Pharm Biopharm 2003; 56: 327–36
- Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008; 364: 298–327
- Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double emulsion solvent extraction/evaporation method. Biomaterials 2001; 22: 231–41
- Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Controlled Release 2008; 127: 137–45